Here are relevant reports on : medical-diagnostics-market

• In Situ Hybridization Market by Offering (Consumables, Instruments, Software), Technology (FISH (DNA FISH, RNA, PNA), CISH), Application (Cancer Diagnostics, Research, Discovery), End User (Hospitals, Pharma & Biotech, Academia) - Global Forecast to 2030

  The global in situ hybridization market, valued at US$1.55 billion in 2024, stood at US$1.64 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$2.35 billion by the end of the period. The growth in the field of in situ hybridization (ISH) is significantly driven by ongoing advancements in technology, including high-sensitivity probes, automated systems, and multiplexing solutions.

  • Published: June 2025
  • Price: $ 4950
  • TOC Available:

• Neuroblastoma Cancer Market by Diagnostics (MIBG Scan, Imaging, Urine Analysis, Biopsy), Treatment (Surgery, Chemotherapy, Radiation therapy, Stem Cell Transplant, Immunotherapy), Staging, Pipeline, Regulatory, Reimbursement - Global Forecast to 2021

  Neuroblastoma is a rare extracranial solid tumor cancer that develops from immature nerve cells found in several areas of the body. It is the most common extracranial solid tumor in childhood.

  • Published: September 2026
  • Price: $ 4950
  • TOC Available:

• Telehealth and Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030

  The global telehealth and telemedicine market, valued at US$83.62B in 2023, is forecasted to grow at a 11.5% CAGR, reaching US$94.14B by 2024 and US$180.86B by 2030. The telehealth and telemedicine market is experiencing significant growth primarily driven by the growing geriatric and medically underserved (especially rural) populations, the growing prevalence of chronic conditions, the benefits of telehealth & telemedicine given the current shortage of physicians and care personnel, and advancements in telecommunication technologies, and expansion of remote patient monitoring (RPM) systems.

  • Published: January 2025
  • Price: $ 4950
  • TOC Available:

• Allergy Diagnostics Market by Product & Service (Consumables, Instruments [Immunoassay Analyzers, Luminometers]), Test Type (In Vivo Tests, In Vitro Tests), Allergen (Food Allergens), End User (Hospital-Based Laboratories) - Global Forecast to 2031

  The global Allergy Diagnostics market, valued at USD 6.23 billion in 2025, stood at USD 6.80 billion in 2026 and is projected to advance at a resilient CAGR of 9.6% from 2026 to 2031, culminating in a forecasted valuation of USD 10.77 billion by the end of the period. Allergy diagnostics fit squarely into this paradigm by enabling early detection of sensitization before severe clinical manifestations occur.

  • Published: February 2026
  • Price: $ 4950
  • TOC Available:

• Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) & Region - Global Forecast to 2026

  The global western blotting market growth is primed to transition from $1.0 billion in 2021 to $1.4 billion by 2026, showcasing a strong CAGR of 6.7%. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Bus & Public Transport Fleet Management Market by Operation (Operations Management, Vehicle Maintenance & Diagnostics, Performance Management, Compliance Management), By Fleet Type (Urban Transit, Suburban & Inter-city, Shuttle) - Global Forecast to 2030

  The Bus & Public Transport Fleet Management System Market is projected to reach USD 15.71 billion by 2030, from USD 8.65 billion in 2025, at a CAGR of 12.7% from 2025 to 2030.The key players include Geotab (Canada), Samsara (US), Verizon Connect (US), Webfleet (Netherlands), MiX Telematics (South Africa), Teletrac Navman (US), Fleet Complete (Canada), Zonar Systems (US), ChargePoint (US), Virta (Finland), Driivz (Israel), Siemens (Germany), ABB (Switzerland), Shell (UK), and LocoNav (India).

  • Published: August 2026
  • Price: $ 4950
  • TOC Available:

• Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030

  The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.

  • Published: July 2025
  • Price: $ 4950
  • TOC Available:

• Cell Culture Equipment Market by Type (Supporting, Bioreactors, Storage), Application (Biopharma Production, Diagnostics, Tissue Engineering), End User (Pharma & Biotech Companies, Hospitals & Diagnostic Labs, Academia), Region - Global Forecast to 2031

  The Cell Culture Equipment market, valued at USD 7.77 billion in 2025, stood at USD 8.36 billion in 2026 and is projected to advance at a resilient CAGR of 11.1% from 2026 to 2031, culminating in a forecasted valuation of USD 14.18 billion by the end of the period. Cell culture equipment encompasses the instruments used to grow and maintain cells in controlled laboratory environments for medical, research, and production purposes.

  • Published: August 2026
  • Price: $ 4950
  • TOC Available:

• Influenza Diagnostics Market by Product (Test Kits, Instruments), Test Type (Traditional (RIDT, Viral Culture, Serological), Molecular (PCR, INAAT- NASBAT, TMABAS)), End User (Diagnostic Laboratories, Hospitals, Clinics) & Region - Global Forecast to 2026

  The global influenza diagnostics market growth is primed to transition from $0.8 billion in 2021 to $1.1 billion by 2026, showcasing a strong CAGR of 7.7%. Key factors driving this growth include increasing demand for rapid disease diagnosis, rising influenza prevalence, and advancements in diagnostic technologies.

  • Published: September 2021
  • Price: $ 4950
  • TOC Available:

• Medical Animation Market by Type (3D, 2D, 4D), Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), Application (Drug MoA, Patient Education), End User (Medical Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021

  This report studies the global medical animation market for the forecast period of 2016 to 2021. This market is expected to reach USD 301.3 Million by 2021 from USD 117.3 Million in 2016, at a CAGR of 20.8%. Major players in the medical animation market include Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Scientific Animations, Inc. (U.S.), INVIVO Communications, Inc. (Canada), Random42 Scientific Communication (U.K.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Blausen Medical Communications, Inc. (U.S.), Trinsic Medical Animation, LLC. (U.S.), Viscira (U.S.), Understand.com (U.S.), and Medmovie, Inc. (U.S.).

  • Published: May 2016
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50